Abstract
The use of a new combination of avelumab + axitinib in patients with metastatic kidney cancer in the first line of treatment
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Медицинский Совет (Borys Grinchenko Kyiv University)
Paper Title
Journal
Date